Kingfa Science & Technology (India) Limited (KINGFA) - Net Assets
Based on the latest financial reports, Kingfa Science & Technology (India) Limited (KINGFA) has net assets worth Rs14.00 Billion INR (≈ $151.45 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs17.54 Billion ≈ $189.71 Million USD) and total liabilities (Rs3.54 Billion ≈ $38.27 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Kingfa Science & Technology (India) Limi strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs14.00 Billion |
| % of Total Assets | 79.83% |
| Annual Growth Rate | 23.64% |
| 5-Year Change | 264.12% |
| 10-Year Change | 966.85% |
| Growth Volatility | 296.43 |
Kingfa Science & Technology (India) Limited - Net Assets Trend (2006–2026)
This chart illustrates how Kingfa Science & Technology (India) Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Kingfa Science & Technology (India) Limi (KINGFA) total market value.
Annual Net Assets for Kingfa Science & Technology (India) Limited (2006–2026)
The table below shows the annual net assets of Kingfa Science & Technology (India) Limited from 2006 to 2026. Also explore net asset momentum of Kingfa Science & Technology (India) Limi to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs14.00 Billion ≈ $151.45 Million |
+91.91% |
| 2025-03-31 | Rs7.30 Billion ≈ $78.91 Million |
+23.98% |
| 2024-03-31 | Rs5.89 Billion ≈ $63.65 Million |
+26.31% |
| 2023-03-31 | Rs4.66 Billion ≈ $50.40 Million |
+21.17% |
| 2022-03-31 | Rs3.85 Billion ≈ $41.59 Million |
+8.65% |
| 2021-03-31 | Rs3.54 Billion ≈ $38.28 Million |
+1.55% |
| 2020-03-31 | Rs3.49 Billion ≈ $37.70 Million |
+7.43% |
| 2019-03-31 | Rs3.24 Billion ≈ $35.09 Million |
+6.29% |
| 2018-03-31 | Rs3.05 Billion ≈ $33.02 Million |
+132.58% |
| 2017-03-31 | Rs1.31 Billion ≈ $14.20 Million |
+9.91% |
| 2016-03-31 | Rs1.19 Billion ≈ $12.92 Million |
+1363.05% |
| 2015-03-31 | Rs81.63 Million ≈ $882.79K |
-28.34% |
| 2014-03-31 | Rs113.91 Million ≈ $1.23 Million |
-42.67% |
| 2013-03-31 | Rs198.68 Million ≈ $2.15 Million |
-20.26% |
| 2012-03-31 | Rs249.16 Million ≈ $2.69 Million |
+0.10% |
| 2011-03-31 | Rs248.91 Million ≈ $2.69 Million |
+2.47% |
| 2010-03-31 | Rs242.91 Million ≈ $2.63 Million |
-1.56% |
| 2009-03-31 | Rs246.76 Million ≈ $2.67 Million |
-7.08% |
| 2008-03-31 | Rs265.57 Million ≈ $2.87 Million |
+20.10% |
| 2007-03-31 | Rs221.12 Million ≈ $2.39 Million |
+10.05% |
| 2006-03-31 | Rs200.92 Million ≈ $2.17 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Kingfa Science & Technology (India) Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 640451100000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs6.40 Billion | 45.77% |
| Common Stock | Rs135.51 Million | 0.97% |
| Other Comprehensive Income | Rs15.43 Million | 0.11% |
| Other Components | Rs7.44 Billion | 53.15% |
| Total Equity | Rs13.99 Billion | 100.00% |
Kingfa Science & Technology (India) Limited Competitors by Market Cap
The table below lists competitors of Kingfa Science & Technology (India) Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AGF Management Limited
F:A3J
|
$854.17 Million |
|
Beijing Watertek Information Technology Co Ltd
SHE:300324
|
$854.47 Million |
|
Indus Holding AG
XETRA:INH
|
$854.67 Million |
|
Theravance Biopharma Inc
NASDAQ:TBPH
|
$854.78 Million |
|
Formosa Advanced Technologies Co Ltd
TW:8131
|
$854.06 Million |
|
Sunway Co Ltd
SHG:603333
|
$854.01 Million |
|
Liaoning Oxiranchem Inc
SHE:300082
|
$853.88 Million |
|
Korea Circuit Co. Ltd.
KO:007810
|
$853.27 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Kingfa Science & Technology (India) Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 7,286,089,000 to 13,993,087,000, a change of 6,706,998,000 (92.1%).
- Net income of 1,852,585,000 contributed positively to equity growth.
- Dividend payments of 6,000 reduced retained earnings.
- New share issuances of 4,999,992,000 increased equity.
- Other factors decreased equity by 145,573,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs1.85 Billion | +13.24% |
| Dividends Paid | Rs6.00K | -0.0% |
| Share Issuances | Rs5.00 Billion | +35.73% |
| Other Changes | Rs-145.57 Million | -1.04% |
| Total Change | Rs- | 92.05% |
Book Value vs Market Value Analysis
This analysis compares Kingfa Science & Technology (India) Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.35x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 203.13x to 5.35x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-03-31 | Rs28.69 | Rs5828.00 | x |
| 2007-03-31 | Rs31.57 | Rs5828.00 | x |
| 2008-03-31 | Rs37.92 | Rs5828.00 | x |
| 2009-03-31 | Rs35.32 | Rs5828.00 | x |
| 2010-03-31 | Rs35.33 | Rs5828.00 | x |
| 2011-03-31 | Rs36.20 | Rs5828.00 | x |
| 2012-03-31 | Rs36.24 | Rs5828.00 | x |
| 2013-03-31 | Rs28.89 | Rs5828.00 | x |
| 2014-03-31 | Rs16.57 | Rs5828.00 | x |
| 2015-03-31 | Rs12.46 | Rs5828.00 | x |
| 2016-03-31 | Rs149.85 | Rs5828.00 | x |
| 2017-03-31 | Rs127.53 | Rs5828.00 | x |
| 2018-03-31 | Rs254.07 | Rs5828.00 | x |
| 2019-03-31 | Rs267.93 | Rs5828.00 | x |
| 2020-03-31 | Rs287.83 | Rs5828.00 | x |
| 2021-03-31 | Rs292.28 | Rs5828.00 | x |
| 2022-03-31 | Rs317.55 | Rs5828.00 | x |
| 2023-03-31 | Rs384.77 | Rs5828.00 | x |
| 2024-03-31 | Rs485.98 | Rs5828.00 | x |
| 2025-03-31 | Rs601.60 | Rs5828.00 | x |
| 2026-03-31 | Rs1088.45 | Rs5828.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Kingfa Science & Technology (India) Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.24%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.28%
- • Asset Turnover: 1.14x
- • Equity Multiplier: 1.25x
- Recent ROE (13.24%) is above the historical average (1.30%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 13.02% | 3.24% | 1.44x | 2.78x | Rs6.08 Million |
| 2007 | 13.27% | 2.94% | 1.65x | 2.73x | Rs7.24 Million |
| 2008 | 20.19% | 4.60% | 1.46x | 3.00x | Rs27.06 Million |
| 2009 | -7.43% | -1.55% | 1.52x | 3.15x | Rs-43.01 Million |
| 2010 | -0.06% | -0.01% | 1.40x | 3.21x | Rs-24.44 Million |
| 2011 | 4.21% | 0.75% | 1.48x | 3.78x | Rs-14.41 Million |
| 2012 | 0.10% | 0.02% | 1.70x | 3.53x | Rs-24.67 Million |
| 2013 | -25.41% | -3.22% | 1.85x | 4.27x | Rs-70.35 Million |
| 2014 | -74.42% | -4.77% | 1.74x | 8.98x | Rs-96.16 Million |
| 2015 | -37.27% | -1.39% | 1.82x | 14.74x | Rs-38.58 Million |
| 2016 | 9.04% | 3.44% | 1.36x | 1.93x | Rs-11.43 Million |
| 2017 | 9.02% | 2.77% | 1.06x | 3.07x | Rs-12.91 Million |
| 2018 | 8.07% | 4.10% | 1.25x | 1.58x | Rs-58.89 Million |
| 2019 | 5.87% | 2.72% | 1.27x | 1.70x | Rs-133.94 Million |
| 2020 | 7.06% | 3.32% | 1.24x | 1.71x | Rs-102.42 Million |
| 2021 | 1.50% | 0.85% | 0.93x | 1.90x | Rs-300.76 Million |
| 2022 | 7.97% | 2.92% | 1.20x | 2.28x | Rs-78.25 Million |
| 2023 | 17.47% | 5.80% | 1.39x | 2.17x | Rs348.11 Million |
| 2024 | 20.82% | 8.24% | 1.50x | 1.69x | Rs636.65 Million |
| 2025 | 20.98% | 8.76% | 1.51x | 1.59x | Rs799.94 Million |
| 2026 | 13.24% | 9.28% | 1.14x | 1.25x | Rs453.28 Million |
Industry Comparison
This section compares Kingfa Science & Technology (India) Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $8,529,824,500
- Average return on equity (ROE) among peers: 8.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Kingfa Science & Technology (India) Limited (KINGFA) | Rs14.00 Billion | 13.02% | 0.25x | $854.11 Million |
| Aarti Industries Limited (AARTIIND) | $11.89 Billion | 21.60% | 1.49x | $1.93 Billion |
| Aarti Surfactants Limited (AARTISURF) | $1.36 Billion | -4.77% | 1.06x | $49.06 Million |
| ABM International Limited (ABMINTLLTD) | $176.83 Million | -10.10% | 0.47x | $5.19 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $11.40 Billion | 10.49% | 0.11x | $348.52 Million |
| Aether Industries Limited (AETHER) | $24.56 Billion | 8.94% | 0.30x | $2.34 Billion |
| Akzo Nobel India Limited (AKZOINDIA) | $7.29 Billion | 29.38% | 1.77x | $1.60 Billion |
| Alkali Metals Limited (ALKALI) | $445.25 Million | -13.03% | 1.09x | $9.65 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $9.90 Billion | 22.72% | 0.39x | $1.03 Billion |
| Ami Organics Limited (AMIORG) | $13.20 Billion | 12.02% | 0.17x | $1.18 Billion |
| Anupam Rasayan India Limited (ANURAS) | $5.07 Billion | 9.71% | 1.61x | $1.49 Billion |
About Kingfa Science & Technology (India) Limited
Kingfa Science & Technology (India) Limited manufactures and supplies reinforced polypropylene compounds, thermoplastics elastomers, and personal protective equipment masks and gloves in India. It also offers engineering plastics including ABS, HIPS, PA, PBT, PC and their alloys; biodegradable nitrile gloves and protective coverall; thermoplastic elastomers under the HYPRENE brand name; POM and L… Read more